IRIS is a consequence of the replacement of CD4+ cells in AIDS patients or of the restoration of the trafficking of immune system cells following plasma exchange (PLEX) to accelerate the removal of natalizumab in MS patients. This evidence concerns the gene CD4 and AIDS.